Rana R. McKay, Wassim Abida, Gerhardt Attard, Boris A. Hadaschik, Takashi Kobayashi, Neal D. Shore, Nianzeng Xing, Mehreteab Aregay, Sarah E. Donegan, Piet Ost. "Phase III, randomized, double-blind, placebo-controlled study of adjuvant saruparib (AZD5305) in patients with BRCAm localized high-risk prostate cancer who are receiving radiotherapy and androgen deprivation therapy (EvoPAR-Prostate02).." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.7_suppl.tps412